Transforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Hong, Ming Hsiang ^a,b   Chou, Yu Chi ^c   Wu, Yi Chieh ^b   Tsai, Kuen Nan ^b,d   Hu, Cheng po ^e   Jeng, King Song ^c   Chen, Mong Liang ^f   Chang, Chungming ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^e TUNGHAI UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CORE PROTEIN; GENOMIC RNA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; NUCLEOCAPSID PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VIRAL PREGENOMIC RNA; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; HEPATOCYTE NUCLEAR FACTOR 4; LEUPEPTIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE; GENE EXPRESSION; HEPATITIS B VIRUS; HEPATOCYTE NUCLEAR FACTOR 4ALPHA GENE; HUMAN; HUMAN CELL; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RNA INTERFERENCE; VIRAL CLEARANCE; VIRUS INHIBITION; VIRUS LOAD; CELL LINE; CELL STRAIN HEPG2; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NORTHERN BLOTTING; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; WESTERN BLOTTING;

HEPATITIS B VIRUS;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LEUPEPTINS; NUCLEOCAPSID; PROMOTER REGIONS, GENETIC; RNA, VIRAL; TRANSFORMING GROWTH FACTOR BETA1; VIRAL CORE PROTEINS; VIRUS REPLICATION;

EID: 84856035448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030360     Document Type: Article

References (67)

1. Chen CJ, Yang HI, Su J, Jen CL, You SL, et al. (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
2. Farazi PA, DePinho RA, (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687.
3. Seeger C, Mason WS, (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68.
4. Moolla N, Kew M, Arbuthnot P, (2002) Regulatory elements of hepatitis B virus transcription. J Viral Hepat 9: 323-331.
5. Tang H, Banks KE, Anderson AL, McLachlan A, (2001) Hepatitis B virus transcription and replication. Drug News Perspect 14: 325-334.
6. Yaginuma K, Koike K, (1989) Identification of a promoter region for 3.6-kilobase mRNA of hepatitis B virus and specific cellular binding protein. J Virol 63: 2914-2920.
7. Yuh CH, Chang YL, Ting LP, (1992) Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol 66: 4073-4084.
8. Yu X, Mertz JE, (1996) Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated. J Virol 70: 8719-8726.
9. Li J, Ou JH, (2001) Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor. J Virol 75: 8400-8406.
10. Raney AK, Johnson JL, Palmer CN, McLachlan A, (1997) Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J Virol 71: 1058-1071.
11. Tang H, McLachlan A, (2001) Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci USA 98: 1841-1846.
12. Yu X, Mertz JE, (2003) Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1. J Virol 77: 2489-2499.
13. Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE Jr, et al. (1992) A transcriptional hierarchy involved in mammalian cell-type specification. Nature 355: 457-461.
14. Li J, Ning G, Duncan SA, (2000) Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 14: 464-474.
15. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, et al. (2004) Control of pancreas and liver gene expression by HNF transcription factors. Science 303: 1378-1381.
16. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, et al. (2003) Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 34: 292-296.
17. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, et al. (2006) Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25: 6101-6112.
18. Bissell DM, Wang SS, Jarnagin WR, Roll FJ, (1995) Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 96: 447-455.
19. Martin-Vilchez S, Sanz-Cameno P, Rodriguez-Munoz Y, Majano PL, Molina-Jimenez F, et al. (2008) The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 47: 1872-1883.
20. Murawaki Y, Nishimura Y, Ikuta Y, Idobe Y, Kitamura Y, et al. (1998) Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis. J Gastroenterol Hepatol 13: 680-684.
21. Akpolat N, Yahsi S, Godekmerdan A, Demirbag K, Yalniz M, (2005) Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. World J Gastroenterol 11: 3260-3263.
22. Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, et al. (1994) Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer 73: 2275-2279.
23. Chou YC, Chen ML, Hu CP, Chen YL, Chong CL, et al. (2007) Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. Hepatology 46: 672-681.
24. Bock CT, Malek NP, Tillmann HL, Manns MP, Trautwein C, (2000) The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro. J Virol 74: 2193-2202.
25. Quasdorff M, Protzer U, (2010) Control of hepatitis B virus at the level of transcription. J Viral Hepat 17: 527-536.
26. Yu X, Mertz JE, (2001) Critical roles of nuclear receptor response elements in replication of hepatitis B virus. J Virol 75: 11354-11364.
27. Cheng YC, Liang CM, Chen YP, Tsai IH, Kuo CC, et al. (2009) F-spondin plays a critical role in murine neuroblastoma survival by maintaining IL-6 expression. J Neurochem 110: 947-955.
28. Lucas Sd S, Lopez-Alcorocho JM, Bartolome J, Carreno V, (2004) Nitric oxide and TGF-beta1 inhibit HNF-4alpha function in HEPG2 cells. Biochem Biophys Res Commun 321: 688-694.
29. Zheng Y, Li J, Ou JH, (2004) Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J Virol 78: 6908-6914.
30. Garcia AD, Ostapchuk P, Hearing P, (1993) Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I. J Virol 67: 3940-3950.
31. Yu X, Mertz JE, (1997) Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily. J Virol 71: 9366-9374.
32. Raney AK, Zhang P, McLachlan A, (1995) Regulation of transcription from the hepatitis B virus large surface antigen promoter by hepatocyte nuclear factor 3. J Virol 69: 3265-3272.
33. Chen ML, Lee KD, Huang HC, Tsai YL, Wu YC, et al. (2010) HNF-4alpha determines hepatic differentiation of human mesenchymal stem cells from bone marrow. World J Gastroenterol 16: 5092-5103.
34. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, et al. (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825-829.
35. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV, (2002) Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 76: 10702-10707.
36. McClary H, Koch R, Chisari FV, Guidotti LG, (2000) Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 74: 2255-2264.
37. Guidotti LG, Morris A, Mendez H, Koch R, Silverman RH, et al. (2002) Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J Virol 76: 2617-2621.
38. Lin SJ, Shu PY, Chang C, Ng AK, Hu CP, (2003) IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B. J Immunol 171: 4708-4716.
39. Kuo TM, Hu CP, Chen YL, Hong MH, Jeng KS, et al. (2009) HBV replication is significantly reduced by IL-6. J Biomed Sci 16: 41.
40. Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, et al. (2009) Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50: 1773-1782.
41. Romero R, Lavine JE, (1996) Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 23: 17-23.
42. Ying C, Li Y, Leung CH, Robek MD, Cheng YC, (2007) Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue. Proc Natl Acad Sci USA 104: 8526-8531.
43. Tseng YP, Wu YC, Leu YL, Yeh SF, Chou CK, (2010) Scutellariae radix suppresses hepatitis B virus production in human hepatoma cells. Front Biosci (Elite Ed) 2: 1538-1547.
44. Cicchini C, Filippini D, Coen S, Marchetti A, Cavallari C, et al. (2006) Snail controls differentiation of hepatocytes by repressing HNF4alpha expression. J Cell Physiol 209: 230-238.
45. Ishikawa F, Nose K, Shibanuma M, (2008) Downregulation of hepatocyte nuclear factor-4alpha and its role in regulation of gene expression by TGF-beta in mammary epithelial cells. Exp Cell Res 314: 2131-2140.
46. Huang S, He X, Ding J, Liang L, Zhao Y, et al. (2008) Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 123: 972-978.
47. Takagi S, Nakajima M, Kida K, Yamaura Y, Fukami T, et al. (2009) MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle. J Biol Chem 285: 4415-4422.
48. Hong YH, Varanasi US, Yang W, Leff T, (2003) AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 278: 27495-27501.
49. Wang B, Cai SR, Gao C, Sladek FM, Ponder KP, (2001) Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4 alpha in rat liver. Hepatology 34: 979-989.
50. Rechsteiner M, Rogers SW, (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21: 267-271.
51. Le Jossic C, Glaise D, Corcos L, Diot C, Dezier JF, et al. (1996) trans-Acting factors, detoxication enzymes and hepatitis B virus replication in a novel set of human hepatoma cell lines. Eur J Biochem 238: 400-409.
52. Mizuguchi T, Mitaka T, Hirata K, Oda H, Mochizuki Y, (1998) Alteration of expression of liver-enriched transcription factors in the transition between growth and differentiation of primary cultured rat hepatocytes. J Cell Physiol 174: 273-284.
53. Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, et al. (2006) Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev 20: 2293-2305.
54. Watt AJ, Garrison WD, Duncan SA, (2003) HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 37: 1249-1253.
55. Kakumu S, Ito Y, Takayanagi M, Yoshioka K, Wakita T, et al. (1993) Effect of recombinant human transforming growth factor beta 1 on immune responses in patients with chronic hepatitis B. Liver 13: 62-68.
56. Yang G, Liu A, Xie Q, Guo TB, Wan B, et al. (2007) Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 19: 133-140.
57. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
58. Billerbeck E, Bottler T, Thimme R, (2007) Regulatory T cells in viral hepatitis. World J Gastroenterol 13: 4858-4864.
59. Li S, Gowans EJ, Chougnet C, Plebanski M, Dittmer U, (2008) Natural regulatory T cells and persistent viral infection. J Virol 82: 21-30.
60. Mills KH, (2004) Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4: 841-855.
61. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, et al. (2005) Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41: 771-778.
62. Chou YC, Jeng KS, Chen ML, Liu HH, Liu TL, et al. (2005) Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. J Virol 79: 1813-1823.
63. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P, (1979) Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281: 646-650.
64. Li J, Buckwold VE, Hon MW, Ou JH, (1999) Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol 73: 1239-1244.
65. Calvert J, Summers J, (1994) Two regions of an avian hepadnavirus RNA pregenome are required in cis for encapsidation. J Virol 68: 2084-2090.
66. Biermer M, Puro R, Schneider RJ, (2003) Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol 77: 4033-4042.
67. Borlak J, Niehof M, (2009) HNF4alpha and HNF1alpha dysfunction as a molecular rational for cyclosporine induced posttransplantation diabetes mellitus. PLoS One 4: e4662.